Shows
藥企哪裡學Ep.21【CreareCmu 百大藥業職人系列】IQVIA商業分析師｜了解自己的內在驅動力，而不是一昧追求名片上的Title｜ft. 王偉如 (下集)#2025 藥企哪裡學 Podcast #【CreareCmu 百大藥業職人系列】
🌟節目單元目的：
邀請各個在業界大放異采的優秀藥業職人來到本節目，
分享他們過去一路走到業界的人生經歷，
每個位置都有它獨特的任務和工作型態，
究竟這些業界精英們是如何在他們各自的領域混的風生水起？
一起來聽聽他們是如何去譜寫出自己的故事吧！
-------------------------------------------------------------
Ep.21【CreareCmu 百大藥業職人系列】
繼上集針對商業分析師的介紹：
今天的來賓我們邀請到了目前受任於IQVIA 商業分析師的王偉如學姊。學姊畢業於臺北醫學大學的臨床藥學碩士及中國醫藥大學藥學系，之前在輔大醫院當臨床藥師～乍聽之下這兩個工作性質好像差很多！？但學姊表示其實也有蠻多相似的地方呢～而作為藥品的商業分析師相較於作為臨床藥師時可能一天幫助10幾位患者，直接協助市場上藥品也能幫助到更大量的患者！
這集學姊繼續介紹了一些藥廠市場調查使用到的統計工具，也給商業分析師有興趣的同學的很實用的建議！最後也很暖心的給了我們職涯選擇與人生追求方面的啟發，有興趣的聽眾們絕對要點進來聽喲～
-------------------------------------------------------------
🌟本集精彩內容重點大綱：
1(00:47) 藥廠市場調查使用到的統計工具&AI
2(05:32)製作自媒體的契機 - 自我探索、決策
3(07:15)建議對商業分析師有興趣的同學做些什麼功課呢
4(14:14)怎麼評估職涯選擇是否符合自己的理想
5(17:14)職涯選擇與了解自我
-------------------------------------------------------------
🌟本集核心思維摘要：
1. 對這個領域的職業有興趣的觀眾們可以學習Excel、Power BI等工具，也要從思維方面開始練習看圖表來解讀、運用到策略設計上。
2.推薦Kaggle平台練習數據分析
3.大學期間可參與實習、行銷、市場調查專案來增加經驗，有機會一畢業就擔任商業分析師！(學校生物統計學建議要好好學！
4. Q：如何判斷自己對這個職業有沒有興趣？ A：對事情發生背後的邏輯很感興趣、喜歡用數據說故事、喜歡跨團隊溝通(KOL、PM、Patient..)
5.除了這些實務上的建議，學姊也分享了很多醫藥相關學生會遇到的煩惱、建立內在驅動力、取得工作生活平衡的Tips，內容太豐富，親自聆聽更能根據自身狀況受到啟發唷～
-------------------------------------------------------------
歡迎填寫以下回饋表單與我們分享您的心得與回饋喔！
https://forms.gle/6WiDd2kT4KEDw7eD6
👉歡迎追蹤我們的Instagram：@crearecmu | 中國醫 職涯發展研究社
也歡迎用IG聯繫我們，與我們分享你的心得與回饋哦！
--
Hosting provided by SoundOn 2025-07-2824 min
藥企哪裡學Ep.20【CreareCmu 百大藥業職人系列】IQVIA商業分析師｜站在更宏觀的位置幫助患者用藥｜ft. 王偉如 (上集)#2025 藥企哪裡學 Podcast #【CreareCmu 百大藥業職人系列】
🌟節目單元目的：
邀請各個在業界大放異采的優秀藥業職人來到本節目，
分享他們過去一路走到業界的人生經歷，
每個位置都有它獨特的任務和工作型態，
究竟這些業界精英們是如何在他們各自的領域混的風生水起？
一起來聽聽他們是如何去譜寫出自己的故事吧！
-------------------------------------------------------------
Ep.20【CreareCmu 百大藥業職人系列】
今天的來賓我們邀請到了目前受任於IQVIA 商業分析師的王偉如學姊。學姊畢業於臺北醫學大學的臨床藥學碩士及中國醫藥大學藥學系，之前在輔大醫院當臨床藥師～乍聽之下這兩個工作性質好像差很多！？但學姊表示其實也有蠻多相似的地方呢～而作為藥品的商業分析師相較於作為臨床藥師時可能一天幫助10幾位患者，直接協助市場上藥品也能幫助到更大量的患者！
接下來就讓學姊帶我們了解這個少見卻對藥廠策略、患者需求聲音重要的角色吧～
-------------------------------------------------------------
🌟本集精彩內容重點大綱：
1(00:51) 來賓自我介紹&職涯選擇
2()臨床藥師工作內容
3(07:59)為何想從醫院藥師轉職到業界做市場分析師
4(09:29)商業分析師的工作內容
5(16:40)轉職後最不適應什麼呢？
6(18:39)近代藥物市場的影響與變化、如何分析
-------------------------------------------------------------
🌟本集核心思維摘要：
1. 商業分析師的工作內容：了解藥品在市場上的表現、了解醫師對疾病/藥物的看法、幫助藥廠擬定行銷策略、跟醫師/藥師/病人訪談討論藥物使用狀況 — 最常對接窗口：藥廠行銷部
2.跨領域溝通的能力很重要，在做臨床藥師時，會需要跟藥師/醫師/護理師及病患溝通，要依據不同執業調整講法，在業界工作也是，對外(ex.產品經理)對內(各個部門)也要調整溝通內容，才能了解大家的需求。
3.藥師做藥物商業分析師的好處：因為我們對藥理、疾病機轉比較熟，所以在跟醫師做訪談時，比較知道該如何問&在哪方面可以更深入的詢問。
4.藥廠/顧問公司手上可能有不止一個案子，而醫院工作內容比較固定，在顧問公司執業就相較不確定每日的工作內容與工時。
5.現今藥廠較在意病患的需求，常常會做深度訪談與了解Patient Jorney
深度訪談：大致訪綱，等到實際與病人訪談時再根據特別的點深入詢問
Patient Jorney：病人從發病到確診到用藥的經驗、照護者的經驗
-------------------------------------------------------------
歡迎填寫以下回饋表單與我們分享您的心得與回饋喔！
https://forms.gle/6WiDd2kT4KEDw7eD6
👉歡迎追蹤我們的Instagram：@crearecmu | 中國醫 職涯發展研究社
也歡迎用IG聯繫我們，與我們分享你的心得與回饋哦！
--
Hosting provided by SoundOn 2025-07-2528 min
Daily Market DownloadIQVIA Second-Quarter 2025 Financial ResultsThis document presents IQVIA's financial performance for the second quarter and first half of 2025, highlighting revenue growth, net income, and adjusted EBITDA. The report details segment-specific revenue contributions from Technology & Analytics Solutions (TAS), Research & Development Solutions (R&DS), and Contract Sales & Medical Solutions (CSMS), noting strong performance in TAS. Key metrics like R&D Solutions backlog and bookings are provided, indicating future business. Additionally, the document outlines the company's financial position, including cash, debt, and share repurchases, and offers updated full-year 2025 financial guidance. The report also includes reconciliations of non-GAAP financial measures to comparable GAAP figures, along with cautionary statements...2025-07-2212 min
The IQVIA PodcastDebunking value, access, & pricing myths: Episode 1 | Centralized EU HTA will never happenWelcome to “Debunking Value, Access & Pricing Myths”—a podcast series from IQVIA’s Value and Payer Evidence team where we separate fact from fiction on some of the most persistent misconceptions in the world of healthcare pricing and access.In this debut episode, your host Rebecca Coady, Principal at IQVIA, is joined by her colleague and EU HTA expert, Sian Tanner. Together, they take on a myth that's loomed large in the industry for decades: “A centralized EU HTA will never happen.”Sian, who leads IQVIA’s EU HTA Solutions offering, unpacks what the reality of EU HTA impl...2025-07-0916 min
The Astonishing Healthcare PodcastAH071 - A Look at What's Really Driving Drug Spend, and How it Impacts Us, with IQVIA's Michael KleinrockThis episode of the Astonishing Healthcare podcast features Michael Kleinrock, Director, Research Development at the IQVIA Institute for Human Data Science. We explore key highlights from their most recent annual report - Understanding the Use of Medicines in the U.S. 2025 - with an eye toward implications for plan sponsors and the health benefits market. What are the key drivers of higher drug spend beyond GLP-1s? At what cost do consumers abandon prescriptions at the counter? How is biosimilar adoption going, and what impact is it having on trend? We answer these questions and many more, including how...2025-06-2736 minThe IQVIA PodcastAI for R&D: Episode 9 | Agentic AI for Clinical TrialsThis episode focuses on how IQVIA is innovating with agentic AI to drive efficiency and quality in clinical trials. In this episode you will: Discover how agentic AI can be leveraged to enhance efficiency and quality in clinical trials and help increase the chance of success. See how an agentic AI approach can optimize site selection, trial design, and other critical elements in clinical trials. Learn about using agentic AI to identify new indications and targets in early clinical development by analyzing data from multiple databases. Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s...2025-06-0917 min
Leben mit Aktien | Der Podcast für Anleger mit WeitblickStreit um US-Schulden: White House Downgrade! | Plus: Trump gegen Big Pharma: Novo Nordisk, United Health, IqviaPodcast Leben mit Aktien
Das Ganze sehen: Die Ratingagentur Moody’s hat die Kreditwürdigkeit der USA herabgestuft – zum Ärger von Donald Trump. Die Folgen für die Märkte – und was Anleger beachten müssen (ca. Min. 6)
Das liegt im Trend: Nun legt sich Trump mit der Pharmalobby an und will die Preise für verschreibungspflichtige Medikamente radikal senken. Gelingt es ihm, das teure System zu reformieren? Und welche Folgen hat dies für Pharmakonzerne? Wir erklären es an drei unterschiedlichen Beispielen: Novo Nordisk, United Health und Iqvia (ca. Min. 18)
Und um diese Wertpapiere ge...2025-05-2148 min
Citeline PodcastsTaking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker SpitzerWhile few doubt the opportunity represented by real-world evidence, some concerns remain about its validity compared to traditional forms of clinical evidence, particularly among regulators. To address these concerns, IQVIA Consumer Health’s vice president of global research and development and real-world evidence services, Volker Spitzer, suggests that incorporating some elements of traditional trials, such as randomization, is a good way to persuade regulators that RWE can be used for consumer health innovation, for example in generating new claims or supporting Rx-to-OTC switch. Looking forward, Spitzer is excited about the ways in which digital health tools and artificial intelligence can be...2025-05-2029 min
The AI in Business PodcastThe Future of Adverse Event Detection in Healthcare and Life Sciences - with Marie Flanagan of IQVIAToday’s guest is Marie Flanagan, Director of Product Management in Digital Projects and Solutions at IQVIA, who joins us to explore the overlooked intersection of AI and safety workflows in life sciences. As the industry experiences an explosion in the volume and diversity of data—from social media and call centers to audio and video files—Marie outlines the mounting challenges for pharmacovigilance and the opportunities AI is unlocking for healthcare and life sciences leaders. Marie discusses how advancements in voice-to-text transcription and automation are helping safety teams manage massive datasets, pinpoint potential risks, and reallocate human resources toward...2025-05-0621 minCiteline PodcastsEverything You Wanted To Know About Real World Evidence, With IQVIA’s Volker SpitzerThe potential for real world evidence (RWE) is huge, according to enthusiasts, but to the uninitiated it can seem like a complicated and forbidding subject. In this Over the Counter double episode, IQVIA Consumer Health’s vice president of global research and development and real-world evidence services, Volker Spitzer, makes understanding real world evidence easy. We start with the basics, with what it is and what companies need to know about it, and what the key difference is with randomised control trials. Many companies are already using real world evidence, Volker notes, and he extracts some key lessons for companies in...2025-05-0641 minThe IQVIA PodcastThe malaria response in perspectiveThis podcast features malaria experts Caroline Boulton (Global Program Head, Malaria, at Novartis); Sherwin Charles (CEO, Goodbye Malaria); and Carlos Chaccour (Researcher and Visiting Scholar, Navarra Institute for International Development). The conversation delves into the current malaria response, examining shifts in international funding, R&D innovations, drug resistance challenges, emerging prevention tools, and the impact of climate change.The podcast is hosted by IQVIA’s Daniel Mora-Brito, Engagement Manager, Global Health, EMEA Thought Leadership.2025-04-2338 minThe IQVIA PodcastMedTech Business Insights: Episode 12 | Top MedTech Trends in 2025In this episode, IQVIA MedTech experts Michelle Edwards and Michaela Miller discuss key trends shaping the MedTech industry in 2025. The conversation covers advancements in 3D printing, real-world evidence (RWE), and clinical AI, among others. Read Ten MedTech Trends to Watch in 2025 to learn more. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Michelle Edwards, Practice Lead, U.S. MedTech Real World and Clinical Solutions, IQVIA2025-04-1813 minThe IQVIA PodcastInformation Management Business Insights and Trends: Episode 7This podcast episode features a discussion between Jeff Pilch from IQVIA and Sanjay Mistry from Molnlycke. Together, they explore the journey of how their companies collaborated to solve a significant business problem related to customer master data management (MDM). Sanjay explains the challenges Molnlycke faced in defining and managing customer data across different units, which hindered their ability to perform basic analytics and customer segmentation. Jeff and Sanjay then discussed the solutions proposed by IQVIA, emphasizing a practical, incremental approach to implementing MDM and data governance, which helped Molnlycke achieve better data management and business efficiency.Featured...2025-04-1721 minThe IQVIA PodcastHPV in focus: Raising awareness of HPV and its prevention in South AfricaOn International HPV Awareness Day, Dr. Nicola Paul hosts Dr. Tando Gaqana, a passionate HPV vaccine advocate, and Daniel Mora-Brito, IQVIA's thought leader in global health, to discuss the impact of Human Papillomavirus (HPV) in South Africa, highlighting the importance of vaccination and regular screening to prevent HPV-related conditions in Africa.2025-03-0417 min
Cures & CapitalMurray Aitken's guide to biotech & pharma leaders: Navigating great uncertainty and complexityIn this episode, we sit down with Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, to discuss the trends shaping the life sciences industry in 2025 and beyond.How do we navigate the life sciences industry in times of great uncertainty?Murray has observed the life sciences industry for decades and lays out his balanced perspective of the state of the industry and the underlying uncertainties, challenges and opportunities. This episode is a must-watch for anyone who wants to know what is going on in the industry. If you want t...2025-03-041h 00The IQVIA PodcastAI for R&D: Episode 8 | AI for Indication SelectionThis episode focuses on using AI for indication selection and prioritization to optimize the value of clinical development planning. In this episode you will: Discover how AI can identify indications with the greatest probability of success and areas of untapped opportunity. See how AI can be leveraged to prioritize hundreds of indications into high-potential opportunities rapidly. Learn about using AI to look at clinical trial data to help predict the future competitive intensity for an indication. Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutio...2025-01-2814 minThe IQVIA PodcastPolio Eradication: Episode 2 | Voices from the fieldIn this episode, Ekra Yao shares his view of the ongoing efforts and strategies in the fight against polio in Africa.2025-01-2818 minThe IQVIA PodcastPolio Eradication: Voices from the fieldIn this episode, Ekra Yao shares his view of the ongoing efforts and strategies in the fight against polio in Africa.2025-01-2822 min
The AI News Daily BriefAI Chip Controls Impact, OpenAI's Regulation Blueprint, and Nvidia-IQVIA Partnership in HealthcareIn this episode, Michelle discusses the ramifications of AI chip export controls on Nvidia and the broader AI professional community, highlighting the challenges and concerns arising from these restrictions. The episode explores OpenAI's proposed framework for AI regulation and the call for increased federal support to ensure responsible AI development. Michelle delves into the partnership between Nvidia and IQVIA, examining its potential to revolutionize healthcare through advanced AI applications. Additionally, the episode covers Microsoft's formation of a new AI engineering group, emphasizing its strategic focus on advancing AI technology. The episode concludes with insights into how these developments are shaping...2025-01-1311 minThe IQVIA PodcastMedTech Business Insights: Episode 11 | Harnessing the Potential of GenAI in HealthcareIn this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics shares her perspectives on the potential of GenAI to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks.Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Vishakha Sharma, Ph.D., Senior Principal...2025-01-0721 min
Data Analytics ChatHow AI and Generative AI is Transforming Healthcare, with Amit Shukla (VP for Global Consulting Services at IQVIA)Send us a textIn this episode of Data Analytics Chat, we explore how AI and Generative AI is transforming the healthcare industry.Amit Shukla, VP for Global Consulting Services at IQVIA, joins us. Amit shares his insights on the impact of AI and generative AI in the healthcare sector. We explore the advancements in drug discovery, data integration, and patient outcomes, as well as the challenges of implementing AI technologies. We discuss how healthcare organisations can become more data-driven and build a culture of innovation, making healthcare more efficient and ac...2025-01-0645 minThe IQVIA PodcastLaunch Excellence: Episode 10 | Achieving Oncology Launch ExcellenceJoin IQVIA Thought Leaders, Kirstie Scott and Stefan Lutzmayer, to explore how to translate the promise of ground-breaking oncology therapies into commercially successful launches. Learn about the evolving oncology landscape, and how to navigate a fluid and challenging commercial environment to achieve Oncology Launch Excellence.2024-12-1716 min
Molecule to Market: Inside the outsourcing spaceBaking success to IQVIA exitIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tessa Pugh, ex-CEO & Co-Founder at PharmaReview.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tessa, covering:
How Tessa's bullish attitude led to her becoming a co-founder at PharmaReview
Being the 'less educated person in the office', and using that to drive the growth of the business
Opting not to leave after the sale of the business, and becoming the CEO
Being the star player within a PE portfolio, leading to a qu...2024-11-2955 minThe IQVIA PodcastAI for R&D: Episode 7 | AI for Successful Clinical DevelopmentIn this episode you will: Discover how AI can predict the success of clinical trials in terms of efficacy, regulatory approval, operational feasibility, reimbursement attainment and product uptake. Learn why AI can give us deeper insights by analyzing unstructured data for better-informed clinical development decisions. See how an agentic AI approach can speed up what would take months and weeks manually, to days and hours, while looking at even more information for the analysis. Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions2024-11-0421 min
Community CornerIqvia Holdings Behavior - Episode #651Welcome back to the Community Corner podcast! Today we're exploring the behavioral finance logic of Iqvia Holdings! Don't forget to subscribe and leave a like to stay tuned for future episodes! Follow us on Instagram - @communitycorner_podcast Timecodes: 0:15 - Introduction 2:15 - Early Breakthroughs 4:01 - Iqvia Holdings's Role in the Future2024-10-0910 min
C-SuiteRivoluzionare la Sanità: Il potere dei Big Data - Intervista a Antonella Levante (IQVIA):Dall’importanza dei big data ai benefici per i cittadini prodotti dalla Human Data Science, fino all’applicazione della Gen Ai in sanità.Antonella Levante, Senior Vice President & General Manager Italy & Greece di IQVIA, ai microfoni di Sanità33, fa il punto sulla visione di un gruppo internazionale come IQVIA.2024-09-2714 minThe IQVIA PodcastSFE Insights: Episode 2 | Predictive triggers: Optimizing patient careTune in to the latest episode of the IQVIA SFE Insights Podcast as Lakshdeep Singh, Senior Principal at IQVIA, and Goksu Dogan, Senior Principal in the Artificial Intelligence and Machine Learning Solutions team, explore the role of predictive analytics and real-time triggers in optimizing HCP engagement and improving patient outcomes. Discover how AI/ML-powered solutions are revolutionizing the pharmaceutical industry and providing actionable insights that drive better business results. Don't miss this insightful discussion!2024-09-1812 minThe IQVIA PodcastClinical research in Egypt and Saudi ArabiaIQVIA Vice President for Clinical Operations Gjon Mirdita who oversees site management in the EMENA region shares his impressions on clinical operations from his recent visit to Egypt and Saudi Arabia, including the potential of clinical operations in these countries and the Middle East as a whole, IQVIA's work and cooperation with stakeholders in the region, and the development and growth of the teams and the individuals.2024-09-1707 minThe IQVIA PodcastIQVIA MedTech Business Insights: Episode 11 | Harnessing the Potential of GenAI in HealthcareIn this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics, shares her perspectives on the potential of Generative AI (GenAI) to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks released by the World Health Organization. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured S...2024-09-1321 minThe IQVIA PodcastLaunch Excellence: Episode 9 | US Edition Part II: The Rewrite of the Business of LaunchElyse Munoz, IQVIA’s US Director of Research and Insights, joins the podcast to discuss insights from the second paper of a three-part series, all about optimizing a US launch. Expect to learn about what impacts the optimization phase of a US launch: patient adherence, market access in the US context (and how it’s different from Europe), and direct-to-consumer advertising (prohibited in other major markets).2024-09-1315 minThe IQVIA PodcastLung Cancer in the Middle EastIQVIA's Vice President for Tech & Services in the Middle East, Rauf Mohamed spoke with Johnson & Johnson Managing Director for Innovative Medicine in the Gulf Region, Pedro Matos Rosa about lung cancer in the region. Pedro and Rauf discussed the severity of lung cancer and its prevalence throughout the region, key stats and insights, the progress in the fight against this cancer, and the need for more initiatives in the region to help fight against lung cancer.2024-08-2726 minThe IQVIA PodcastWorld Hepatitis Day: Eliminating Hepatitis C - Lessons from EgyptIn 2023, the WHO and the World Bank recognized Egypt's remarkable achievement in eradicating hepatitis C. This podcast features a special guest, H.E. Dr. Mohamed Hassany, Assistant to the Minister of Health for Public Health and Presidential Initiatives in Egypt, who shares the nation's journey from having one of the highest incidence rates of hepatitis C to its successful elimination, and shares lessons and insights on how the strategy that was implemented can be adapted in other low- and middle-income countries.2024-08-0617 minThe IQVIA PodcastLaunch Excellence: Episode 8 | Patient Engagement and Support ServicesIn episode 8, IQVIA EMEA Thought Leaderships’ lead on patient engagement, Meike Madelung, joins the podcast to talk about why patient engagement and support services (PES) are important for launch. Hear examples of how PES can benefit patients, healthcare systems, and pharma companies striving for launch success.2024-08-0614 min
Pioneers by MultimodalAccelerating Healthcare Innovation using AI with Raja Shankar, VP of Machine Learning at IQVIAJoin Ankur Patel as he interviews Raja Shankar, Vice President of Machine Learning at IQVIA. In this conversation, they explore the transformative role of machine learning in drug discovery and clinical decision support within the healthcare industry. Raja shares his inspiring journey into the field of AI and discusses the challenges and opportunities of implementing AI in healthcare, including data integration and prompt engineering. They also examine how AI can transform workflows, enhance productivity, and automate triage processes to reduce waiting times and improve patient experiences. The discussion highlights AI's potential to aid clinical decision-making by analyzing real-world data...2024-08-0650 minThe IQVIA PodcastOneKey Reference Datasets: Episode 9 | Smith and Nephew Improved Operational Data Efficiency with OneKey’s EcosystemThis podcast episode explores how data-driven solutions are transforming the healthcare industry. Our guest is Bob Forcier, a key figure at Smith and Nephew who plays a pivotal role in leveraging data for operational improvements. Bob shares insights on how Smith and Nephew define operational efficiency and the critical role OneKey data plays in achieving it. He and OneKey’s Charles Wallace, Associate Director Product Offering, discusses the integration process, quantifiable metrics, and the benefits of using OneKey data. Listen to the podcast to learn about Smith and Nephew’s success story and how OneKey has streamlined their operations....2024-07-2217 minThe IQVIA PodcastEvolving with IQVIA: Agile Brand Promotion Episode 8 | Business Insights: Confronting Aspirations vs. The Realities of Your Omnichannel Engagement StrategyOmnichannel is now a top priority for most pharma brand and commercial leaders. There’s a clear focus to embed omnichannel engagement and drive differentiating, consumer-like experiences within campaign plans and brand strategies. And while every organization is at a different maturity level, at IQVIA, we have seen a common trend that progress, regardless of your maturation, is harder and more limited than ever. In this podcast, IQVIA’s Matthew Smith and Matthew Doyle host a roundtable discussion with Takeda’s Chris Weber, Head of Customer Experience, U.S. Oncology, Julia Allen, Product Marketing Director, from Fresenius Medical...2024-07-1624 minThe IQVIA PodcastOneKey Reference Datasets: Episode 8 | OneKey Data and MedTech Market ActivatorIn today’s complex healthcare landscape, understanding your customers is more challenging than ever, and as such, medical device and diagnostic line partners face significant gaps and unmet needs for their commercial teams. IQVIA’s latest solution, the MedTech Market Activator, fueled with OneKey data, empowers commercial teams with comprehensive insights and tools to support strategic growth and daily activities. Tune in to this podcast to learn from data and product experts about how the MedTech Market Activator will provide your teams the agility needed to make a greater impact.Featured Speakers:Shauntell Kelley, Director of OneK...2024-07-0114 min
The Weekly Snapshot - MedtechAI MedTech Innovations: Insights from Sanara MedTech and IQVIA's Latest AchievementsRecent developments in the healthcare and technology sectors show promising progress. Sanara MedTech's stock has seen a rise of 3.6% on NASDAQ. Meanwhile, PEAK:AIO is dedicating efforts towards advancing AI in healthcare. Additionally, IQVIA's SmartSolve® eQMS has been recognized with the 2024 MedTech Breakthrough Award for the Best Use of Artificial Intelligence in Healthcare, highlighting innovations in the industry.2024-06-2806 min
The MM+M PodcastCannes 2024: Shaping the future of healthcare marketing, a podcast sponsored by IQVIAPersonalization. A ”cookieless future.” Just two of the myriad themes discussed at Cannes last week — and highlighted during this IQVIA-sponsored podcast.Step into the future of health media at the MM+M Media Summit on October
30th, 2025 live in NYC! Join top voices in pharma marketing for a full
day of forward-thinking discussions on AI, streaming, retail media, and
more. Explore the latest in omnichannel strategy, personalization, media
trust, and data privacy—all under one roof. Don’t wait—use promo code
PODCAST for $100 off your individual ticket. Click here to register!
AI Deciphered is back—live in New York City this Novemb...2024-06-2523 min
The MM+M PodcastA hammer for every nail: Exploration of AI at Cannes, a podcast sponsored by IQVIAThis IQVIA-sponsored podcast drills deep to highlight very specific ways AI can supercharge healthcare marketing efforts.Step into the future of health media at the MM+M Media Summit on October
30th, 2025 live in NYC! Join top voices in pharma marketing for a full
day of forward-thinking discussions on AI, streaming, retail media, and
more. Explore the latest in omnichannel strategy, personalization, media
trust, and data privacy—all under one roof. Don’t wait—use promo code
PODCAST for $100 off your individual ticket. Click here to register!
AI Deciphered is back—live in New York City this November 13th.Join
leaders fr...2024-06-2519 min
In Practise InterviewsVeeva Align, Link, and OpenData vs IQVIA OneKeyVisit https://inpractise.com/articles/veeva-align-link-and-opendata-vs-iqvia-onekey for full transcripts, business analysis, audio, video and more.
Veeva Align, Link, and OpenData vs IQVIA OneKey
Former Head of Align Strategy at Veeva Systems
The executive spent over 7 years at Veeva firstly as a solution consultant working with customers and then heading Veeva's Align and Link products within the core offering.
2024-06-2300 min
IGEPHA im GesprächS7_Vol. 7 – IGEPHA im Gespräch with Thomas HeilHello and welcome to a new episode of IGEPHA im Gespräch – the podcast of the Austrian Self Care Association. In this episode of "IGEPHA im Gespräch," Christina Nageler, Managing Director of IGEPHA, welcomes Thomas Heil, Vice President for Consumer Health at IQVIA. Together, they delve into the world of Artificial Intelligence (AI), discussing its potentials and challenges in the self-care sector and beyond. Thomas Heil provides insights into how IQVIA utilizes AI to enable data-driven decisions and describes how the self-care industry can benefit from these analytics. Additionally, he talks about the opportunities and limitations of Generat...2024-06-1115 minThe IQVIA PodcastPatient Support Programs in Africa: Episode 2 | Case management, financial assistance, and the patient journeyIn episode 2, we examine financial assistance or case management: What is a case management approach and the importance of looking at the whole patient journey. 2024-06-1109 minThe IQVIA PodcastPatient Support Programs in Africa: Episode 1 | Patient Needs and Program DesignIn this episode, we examine the needs of patients in the current health systems and the role and potential of patient support programs to improve patient access to reliable and innovative treatments.2024-05-3107 minThe IQVIA PodcastSFE Insights Series: Episode 1 | AIML Powered Referral NetworksTune in as Paige Desmarais, IQVIA SFE Principal, and Ruoxin Li, IQVIA Sr Director in Advanced Analytics, delve into the transformative impact of AI and machine learning on healthcare analytics. In this episode, they explore how these technologies are reshaping provider referral patterns. As patient and provider journeys become increasingly complex, analytics managers and brand product managers seek innovative strategies to identify referral networks more effectively.2024-05-3108 minThe IQVIA PodcastClinical Trials Landscape in the UAE and Middle East: Opportunities, Challenges and Lessons LearnedClinical trials play a significant role in the development of drugs and medical breakthroughs. They are key for the advancement of medicine, although not all stakeholders are aware of their strong impact on patient care. Listen to our podcast with guest speaker Dr. Nawal Al-Kaabi, Senior Advisor and Consultant, Pediatric Infectious Disease at Sheikh Khalifa Medical City, who will walk us through the landscape of clinical trials in the UAE and the region, with a focus on the COVID-19 clinical trial program.2024-05-3023 minThe IQVIA PodcastMedTech Business Insights: Episode 10 | Advancing the Health Equity Journey in MedTechIn this episode, Dr. Shelly Nash, Senior Vice President and Global Chief Medical Information Officer at Fresenius Medical Care, discusses the importance of health equity and access to care in driving better health outcomes. Dr. Nash defines the issue of health equity and shares initiatives and opportunities for medical device and diagnostic companies to accelerate progress and address hurdles along the way. Key highlights include the challenges of data integration and interoperability. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Shelly Nash, DO, FACOOG, Senior Vice...2024-05-2118 minThe IQVIA PodcastConnected CareIQVIA’s Vice President for Genomics and Precision Medicine Joanne Hackett discusses the importance of connected care, digital maturity, and innovation and technology in healthcare.2024-05-2113 minThe IQVIA PodcastThe Expanded Program on ImmunizationLearn about the progress and challenges facing the Expanded Program on Immunization in Nigeria.2024-05-2128 min
How Healing Works with Dr. Wayne JonasIQVIA Survey ImplicationsSend us a textSummaryIn this episode, Dr. Alyssa McManamon and Dr. Wayne Jonas discuss the results of a yearly IQVIA survey on attitudes and access to integrative approaches for whole person cancer care. The survey shows an increase in positive patient attitudes and usage of integrative oncology. However, there is still a gap between what patients want and what health systems offer. Patients are using complementary therapies to improve their survival odds and manage side effects. The survey also highlights barriers to integrative oncology, such as the need for funding, adequate...2024-05-2121 min
The AI in Business PodcastTargeting Providers through Omnichannel Marketing and Patient Personalization - with Tom Hayes and Gareth Dabbs of IQVIAToday’s guests are Tom Hayes and Gareth Dabbs, Senior Director of Product Strategy & Commercialization and Global Technology Product Strategy Lead at IQVIA, respectively. In today’s episode, they come to share two use cases helping to drive quality patient experiences between healthcare and insurance workflows. The first focuses on optimizing omnichannel marketing for compliance. The second use case centers on building trust and value in caretaker support systems through personalized insights. If you’ve enjoyed or benefited from some of the insights in this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what y...2024-05-2126 minThe IQVIA PodcastLaunch Excellence: Episode 7 | Rare Disease Launch ExcellenceIn this episode, Sarah Rickwood and Stefan Lutzmayer discuss key findings from the “From Orphan to Opportunity: Mastering Rare Disease Launch Excellence” white paper. Discover how to navigate the complex rare disease landscape, overcome post-pandemic hurdles, and apply the three pillars of launch excellence to achieve success in rare diseases.2024-05-0118 minThe IQVIA PodcastMedTech Business Insights: Episode 9 | Top MedTech Trends in 2024In this episode, IQVIA’s Raj Stewart and Michelle Edwards dig deeper into IQVIA’s annual “Ten MedTech Trends to Watch” report, which focuses on the key trends impacting the U.S. MedTech industry today. Learn how health equity, the consolidation of health systems, and advances in diagnostics are impacting the need for evidence generation among MedTech manufacturers and suppliers.Read Ten MedTech Trends to Watch in 2024 to learn more. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speakers: Michelle Edwards, Practice Lead, U.S. MedTec...2024-04-2421 minThe IQVIA PodcastAI for R&D: Episode 6 | Benefits of Patient Centricity in DesignThis episode focuses on Patient Centricity in Design and how engaging patients in protocol design can improve clinical outcomes. IQVIA’s Patient Centricity in Design solution helps sponsors optimize study design for patient engagement and patient outcomes, such as incorporating diverse patient preferences, selecting design elements that align with real-world patient experiences and using this knowledge to minimize patient burden. Ivan Petrov, Associate Design Analytics Director is our featured speaker.2024-04-2411 min
Community CornerIqvia Holdings Inc. - Episode #217Welcome back to the Community Corner podcast! Today we're exploring the story of Iqvia Holdings Inc.! Don't forget to subscribe and leave a like to stay tuned for future episodes! Follow us on Instagram - @communitycorner_podcast Timecodes: 0:15 - Introduction 2:15 - Early Breakthroughs 4:01 - Iqvia Holdings Inc.'s Role in the Future2024-04-0205 min
Healthcare MattersS5, Ep 1- New Findings Unveiled: The Economic Path to Increased VaccinationIn this episode of Healthcare Matters, our hosts dive into the impact of pharmacy reimbursement on vaccination rates with guest Vibhu Tewary, researcher and Project Director at IQVIA Institute for Human Data Science. Through discussing a recent study, they reveal how a modest increase in reimbursement can lead to higher flu vaccination rates among Medicaid-covered adults. The episode also touches on the role of pharmacies in public health, the need for policy reform to enhance vaccine accessibility, and the potential for future research to further improve public health outcomes. Among the highlights in this episode:2024-03-2221 min
Life Sciences Data PodcastGet to the Root Cause IQVIA NPA Data | Life Sciences Data Podcast | 3Understanding the root cause of a business issue is core to a successful data project. Nicho recounts his experience as an enterprise architect designing a system to pull IQVIA data into a commercial data warehouse. www.linkedin.com/in/nicholas-mann-80855a1a/www.stratosconsulting.com2024-03-2103 min
The AI in Business PodcastThe Power of eConsent in Healthcare Workflows - with Melissa Easy and Vinita Navadgi of IQVIAToday’s guests are Melissa Easy, Vice President and General Manager of Clinical Technologies and Vinita Navadgi, Sr. Director, Digital Patient Suite at IQVIA. They join us on today’s show to discuss the advantages of optimizing consent workflows through automation, or ‘eConsent’ processes. The conversation delves into the metrics defining the effectiveness of ‘eConsent’ for both patients and healthcare providers, elucidating the role of AI in shaping the broader landscape of clinical trials. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what y...2024-02-1326 min
Voices of a Business SchoolFaculty #9 | Product Launch Excellence in Life Sciences by IQVIA Thought Leader Sarah RickwoodAVT lecturer and IQVIA Throught Leader Sarah Rickwood delve into pharmaceutical launch dynamics, especially post-pandemic, stressing regional variations and the importance of understanding local health systems. It highlights the crucial role of interactive engagement, showcasing higher levels in Excellent launches, particularly outside Europe. The Three Pillars of Post-Pandemic Launch Excellence are introduced, advocating for patient-centric approaches, strategic health system partnerships, and integrated evidence strategies. Early local investment is recommended to address system challenges effectively. Collaborations with health systems are seen as crucial for success, with examples demonstrating improved efficiency and outcomes. Future challenges include increasing demands on health systems...2024-02-1130 min
BioSpaceFast and furious evolution: How to ensure AI is catalyst for positive societal change with Microsoft and IQVIAThis is the second part of our discussion on the evolution of artificial intelligence and its impact on life sciences with guests from Microsoft and IQVIA.
We dive into regulation, real-time management, and AI's various applications and how it can streamline different processes.
We also discuss the cost and affordability of AI; the tremendous investment required and when holding off on new tech is valuable.
Hear how AI is highlighting society's flaws and may become the catalyst for societal change.
Host
Lori Ellis, Head of Insights, BioSpace
2023-12-1231 min
BioSpaceIntegrating AI in life sciences to change employee behavior with Microsoft and IQVIAOver the last year, the reaction to generative AI has changed - and so have behaviors. People are integrating AI to become more productive and it is happening now in healthcare and life sciences. Hear from senior leaders at Microsoft and IQVIA to get their take on how generative AI is impacting productivity, employee engagement and how to mitigate risks.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Matt O’Donnell, Industry Executive Health & Life Sciences, Microsoft
Mike King, Senior Director of Product and Strategy, IQVIA 2023-12-0720 min
L'hôpital du futurPrédire les flux patients des urgences à la sortie de l’hôpital, avec Karim Bensaci« Plus vite on trouve un lit, plus vite on le libère et mieux ça vaut pour tout le monde. »
Karim Bensaci, CTO pour CALYPS Saniia
Cette semaine, @WarcoBrienza cuisine Karim Bensaci sur ses activités d’innovateur dans l’écosystème des soins. CALYPS Saniia est une solution de prédictions des flux patients embarquant de l’intelligence artificielle (IA). À cet égard, elle optimise les ressources d’un hôpital - principalement le personnel soignant et les lits - selon le niveau de tension vécue par celui-ci.
En production au Centre Hospitalier de Valenciennes depuis 2019, des hôpitaux se sont é...2023-11-2400 min
RISE RadioEpisode 18: IQVIA’s Dr. Calum Yacoubian on empowering payers in risk, quality, and health equity with clinical NLPCalum Yacoubian, M.D., director of NLP health care strategy at IQVIA, joins us for the latest episode of RISE Radio, our podcast series that focuses on issues that impact policies, regulations, and challenges faced by health care professionals responsible for quality and revenue, Medicare member acquisition and experience, and/or social determinants of health.In this 21-minute podcast, Dr. Yacoubian discusses natural language processing (NLP) and why it’s vital to use in health care for risk adjustment, quality, social determinants of health, and health equity. About Calum Yacoubian, director of NLP health care...2023-10-2421 min
The Change-maker ConversationsTosin Adenrele, Global Mobility Regional Lead EMEA at IQVIA #11On this episode of The Change-Maker Conversations, Tosin Adenrele, Global Mobility Regional Lead EMEA at IQVIA joins Dr Milena Coupez to share her journey in the Global Mobility space at IQVIA, a leading firm in global provider of advanced analytics, technology and clinical research in life sciences. Tosin discusses her extensive experience in change management, as well as the broader implications and external factors driving global mobility.2023-10-1223 min
The AI in Business PodcastAI Data Management for Clinical Trials - with Melissa Easy and Tim Riely of IQVIAToday’s guests are Melissa Easy, Vice President and General Manager of Clinical Technologies at IQVIA, and Tim Riely, Vice President of Clinical Data Analytics at IQVIA. They return to the program to talk with Emerj Senior Editor Matthew DeMello about the current state of AI in life sciences and clinical trials. Throughout the episode, Melissa and Tim underscore both the ongoing and impending impact of large language models on report writing and other clinical trials-oriented use cases. 2023-07-1316 min
The AI in Business PodcastThe Impact of AI-Enhanced Clinical Trials on Patient Experiences - with Melissa Easy and Tim Riely of IQVIAToday’s guests are Melissa Easy, Vice President and General Manager of Clinical Technologies at IQVIA, and Tim Riely, Vice President of Clinical Data Analytics at IQVIA. They join Emerj Senior Editor Matthew DeMello on the program to talk about the current state of AI in life sciences and clinical trials. Throughout the episode, Melissa and Tim underscore the extent that clinical trials are changing thanks to data, and how life sciences will change as more people seek clinical trials as a form of alternative care. To discover more AI use cases, best practice guides, white papers, frameworks, and mor...2023-07-0525 min
Podcast de AsefarmaConociendo a... Sara Carbajo, Ecommerce Manager de IQVIASara Carbajo es Ecommerce Manager de IQVIA, empresa líder en servicios de información y tecnología para la Salud. Es una apasionada del Ecommerce y tiene una amplia experiencia y conocimientos en el ámbito del autocuidado, así como en el marketplace y las herramientas involucradas para su desarrollo. Comprometida con los datos y con las respuestas que brindan sus análisis, ha contribuido significativamente al avance de la industria farmacéutica en el ámbito digital.2023-06-2223 min
Healthcare MattersS3, Ep 7- How the COVID-19 Pandemic Enhanced the Role of Pharmacists in the Immunization ProcessThe COVID-19 pandemic led to an increased role of pharmacies in the overall immunization process, as they served as key sites of administration for COVID-19 vaccines. The IQVIA Institute for Human Data Science and the Global Healthy Living Foundation (GHLF) released a report today to better understand the trends in vaccine administration in the United States. “[The report is] built into the evidence of how we can address equity, where patients want to get their care, and what are the policy solutions that are important for us to pursue to make our healthcare system more eq...2023-01-1816 min
Pharma Launch SecretsPharma’s NEW Launch Machine: How CX, Data, Multiple $200M - $500M Launches, and Agility Come Together with Indraneel Mukherjee, Senior Principal, Commercial Strategy at IQVIA Strategy ConsultingPharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free GuideIn this episode, Bozidar is joined by Indraneel Mukherjee, Senior Principal, Brand & Commercial Strategy at IQVIA. They cover:Why will new launches not be able to make up for the patent cliff?What is a “hyper-focused launch,” and what are the key ways to execute it?What can big pharma learn from how Google launches products?Subscribe here:Apple: https://apple.co/3micGmFG...2022-11-2347 min
Pharma Launch SecretsPharma’s NEW Launch Machine: How CX, Data, Multiple $200M - $500M Launches, and Agility Come Together with Indraneel Mukherjee, Senior Principal, Commercial Strategy at IQVIA Strategy ConsultingPharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free GuideIn this episode, Bozidar is joined by Indraneel Mukherjee, Senior Principal, Brand & Commercial Strategy at IQVIA. They cover:Why will new launches not be able to make up for the patent cliff?What is a “hyper-focused launch,” and what are the key ways to execute it?What can big pharma learn from how Google launches products?Subscribe here:Apple: https://apple.co/3micGmFG...2022-11-2347 min
The MM+M PodcastPulling at the threads of HCP marketing in an age of data privacy, a podcast presented by IQVIABob Whiting, Director for Digital Media Solutions at IQVIA, talks about the importance of data consent and data consistency in HCP marketing, and how both present opportunities to drive healthcare forward.Step into the future of health media at the MM+M Media Summit on October
30th, 2025 live in NYC! Join top voices in pharma marketing for a full
day of forward-thinking discussions on AI, streaming, retail media, and
more. Explore the latest in omnichannel strategy, personalization, media
trust, and data privacy—all under one roof. Don’t wait—use promo code
PODCAST for $100 off your individual ticket. Click here to reg...2022-06-3022 min
Microdosing[Event: ASCO] Natalie Sacarakis of IQVIANatalie Sacarakis of IQVIA shares how their Cell and Gene Therapy COE can address the unique logistics management and clinical operations challenges around one's CAGT asset and pipeline.2022-06-0405 min
MSL TalkKPIs: Why Quantitative WON’T Work Without Qualitative OutcomesIn this episode, Linda Traylor and Rena Patel join Tom Caravela to share their insights on the evolving landscape of the MSL profession. They discuss the significance of networking, understanding KPIs, and the integration of qualitative outcomes to measure MSL value. The conversation highlights the adaptation of KPIs due to COVID-19 and the shift towards virtual engagement. The guests emphasize the importance of tactical planning and motivation strategies for MSL teams, along with lifelong learning and the benefits of MSL coaching. The episode concludes with tips for top performance and the necessity of continuous learning and adaptability in the field.
2022-05-2437 min
IGEPHA im GesprächS3_Vol. 4 – IGEPHA im Gespräch mit Theresa KretschmerDiese Staffel widmen wir ja den großen Trends in der Self Care und am OTC-Markt und ich denke, einer der wichtigsten Trends unserer Zeit ist das Thema Nachhaltigkeit. Für die Self Care Industrie ist Nachhaltigkeit und Klimaschutz ein Thema, wo die Betriebe viel Verantwortung übernehmen. Die Self Care Industrie bekennt sich ja bekanntlich dazu, einen ganz wesentlichen Beitrag zur Gesundheit der Menschen zu leisten. Und eine ganz zentrale Voraussetzung für ein gesundes Leben ist eine möglichst intakte Umwelt. Wir von der IGEPHA rücken heuer das Thema Nachhaltigkeit ganz besonders in den Fokus und umso mehr freut es...2022-05-0314 min
Elevate Medical Affairs Podcast ChannelEmbedding Communications Strategies in RWE InitiativesIn this episode of the Medical Affairs Professional Society podcast series, "Elevate", we speak about embedding communications in Real-World Evidence strategy with Becky Galbraith, Senior Director, IQVIA Medical and Patient Communications and Barbara Arone, VP Medical Affairs Offerings, IQVIA. Specifically, we explore the necessity to consider communication as an essential element in the planning process for RWE studies. To learn more about how your organization can partner with IQVIA to discover and engage hidden thought leaders, visit Iqvia.com.2022-04-0720 min
Talking HealthTech218 - Creating research-ready real-world data & retaining data sovereignty. Tom Bryant, IQVIALearn about creating research-ready real-world data in this interview with Tom Bryant from IQVIA2022-03-0228 min
Le Journal du Pharmacien[ REDIFFUSION]- Clément Le Dissez - Senior consultant HEOR & Market Access chez IQVIA | Enseignant vacataire à l'Université Paris-Dauphine(Re)Découvrez le parcours de Clément Le Dissez, senior consultant HEOR (Health Economics and Outcome Research) et Market Access chez IQVIA. Clément est spécialisé dans l'accès au marché des médicaments et les études médico-économiques.
IQVIA est une multinationale spécialisée dans les data de santé. La boîte a également élargi ses activités, et propose de l'analyse liée aux données de santé comme le consulting, et prodigue des conseils auprès de différentes structures liées au domaine de la santé (laboratoires pharmaceutiques, mutuelles, hôpitaux).
Dans cet...2022-01-1630 min
Le Journal du Pharmacien12. Clément Le Dissez - Senior consultant HEOR & Market Access chez IQVIA | Enseignant vacataire à l'Université Paris-DauphineClément Le Dissez est senior consultant HEOR (Health Economics and Outcome Research) et Market Access chez IQVIA. En d'autres termes, Clément est spécialisé dans l'accès au marché des médicaments et les études médico-économiques.
IQVIA est une multinationale spécialisée dans les data de santé. La boîte a également élargi ses activités, et propose de l'analyse liée aux données de santé comme le consulting, et prodigue des conseils auprès de différentes structures liées au domaine de la santé (laboratoires pharmaceutiques, mutuelles, hôpitaux).
Dans cet épisode Clé...2021-07-1130 min
IGEPHA im GesprächS1_Vol. 2 – IGEPHA im Gespräch mit Mag. Stefan Baumgartner und Mag. Doris WinklerIn dieser Folge von IGEPHA im Gespräch spricht IGEPHA-Geschäftsführerin Christina Nageler mit ihren Gästen von IQVIA über das IGEPHA Gesamtmarktprojekt. Gestartet wurde dieses Projekt, um konkrete Zahlen zum OTC-Umsatz im Versandhandel zu gewinnen. IQVIA-Geschäftsführer Stefan Baumgartner und Projektkoordinatorin Doris Winkler präsentieren erste Ergebnisse. https://www.iqvia.com/ https://www.linkedin.com/in/stefan-baumgartner-4b43a0a1/ https://www.linkedin.com/in/doris-winkler-57b759b0/ 2021-05-1013 min
Life Science TodayLife Science Today 043 – Charles River, IQVIA, Agios, AlloyOriginally Published as The Niche PodcastCharles River acquires Retrogenix, IQVIA fully acquires Q2 Solutions, Agios sells $1.8B in oncology, and Alloy forges a $75M series C. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-043-1https://tinyurl.com/Niche-043-2https://tinyurl.com/Niche-043-3https://tinyurl.com/Niche-043-4https://tinyurl.com/Niche-043-5 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is...2021-04-0508 min
PharmaTalkRadioRemote Monitoring for Clinical Research in the Digital AgeIn this PharmaTalk podcast, MaryAnne Rizk, PhD, of IQVIA, leads a multi-perspective panel discussion on monitoring in the digital age as data becomes the new currency. Together they discuss how AI and ML are empowering sponsors and sites to predict risk before it happens, how modernization is expanding remote monitoring capabilities and the waterfall impact of that on analytical roles, and how this technology can be leveraged to benefit patient engagement and data standards. Dr Rizk went into deeper detail on this subject at the 2020 DPHARM: Disruptive Innovations conference. Moderator: MaryAnne Rizk, Ph.D. - SVP Digital R&D, IQVIA Gues...2020-09-1824 min
Remote Monitoring for Clinical Research in the Digital AgeIn this PharmaTalk podcast, MaryAnne Rizk, PhD, of IQVIA, leads a multi-perspective panel discussion on monitoring in the digital age as data becomes the new currency.
Together they discuss how AI and ML are empowering sponsors and sites to predict risk before it happens, how modernization is expanding remote monitoring capabilities and the waterfall impact of that on analytical roles, and how this technology can be leveraged to benefit patient engagement and data standards.
Dr Rizk went into deeper detail on this subject at the 2020 DPHARM: Disruptive Innovations conference.
Moderator:
MaryAnne Rizk, Ph.D. - SVP Digital R&D, IQVIA
Gues...2020-09-1825 min
Getting to 50/50: Conversations to Bridge the Gender GapGetting to 50/50: Luck, Persistence, and the Pursuit of Happiness - A Conversation with Mayah Curtis"When your inner dialogue doesn't align with your external environment, things won't turn out right," explains Mayah Curtis. Join Pratima and Mayah as they discuss how through leadership, you can create an environment of empowerment and elevation. ____________________________________________________________Mayah Curtis is a Senior Principal in Commercial Services at IQVIA. With over fifteen years of experience in healthcare analytics and technology consulting services in the pharmaceutical and biotechnology industries, she is widely recognized for her visionary executive leadership, highlighted by a passion for entrepreneurship and organizational growth. Mayah built and led the rapid growth of commercial analytics...2020-09-1441 min
Contém ReferênciaEp 2 - Vírus, Covid 19, Vacinas, Desenvolvimento de medicamentos, Luz no fim do túnelSaudações farmacêuticas!
Sejam bem-vindos ao segundo episódio do Contém Referências!
Neste programa, falaremos sobre o assunto mais em voga no momento, o Covid 19!
Falaremos aqui sobre vírus, vacinas, estudos clínicos, desenvolvimento de medicamentos e os prognósticos que temos no momento para o tratamento desta doença que tanto nos afeta.
Participando do programa:
Gustavo Vidal (Jão / Johnny)
Evandro Semighini (Xita)
Willian Abraham (Mentira)
Gabriel Giassetti (Caraio)
---
Programa gravado e editado com o aplic...2020-08-0457 min
PharmaPills - Pillole dal farmaceuticoPharmapills puntata n.115. AstraZeneca e Iqvia insieme per sviluppare un vaccino anti Covid-19.PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano Lagravinese. In questa puntata parliamo di:Covid-19, Takeda, Antibiotico resistenza, Mieloma Multiplo, HIV.Aziende: AstraZeneca, IQVIA, MSD, Takeda.Persone: Kenneth Frazier (MSD), Rita Cataldo (Takeda Italia).Nuove terapie: Rukobia, belantamab mafodotin.Patologie: HIV, Mieloma Multiplo.Lavoro: Senior CRA, CRA II.Il mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapills www.facebook.com/pharmapills/2020-07-2208 min
SCRS TalksDeploying Digital Technologies to Boost Support to Sites During COVID-19IQVIA Technologies has focused on three important areas for deploying technology to support sites. Melissa Easy from IQVIA discusses with us how technology is affecting sites, sponsors, and CROs and how their approach to technology is changing the relationship. The focus has to be on how technology can make the lives of sites easier, and addressing the concerns sites have specifically around payments and finances. Having one place to direct sites in order to help navigate virtual challenges and technology is one such specific solution proposed by IQVIA. 2020-05-2517 min
Sales Enablement PRO PodcastEpisode 71: Rebecca Bell on Customer Centricity in an Increasingly Virtual WorldShawnna Sumaoang: Hi, and welcome to the Sales Enablement PRO podcast. I am Shawnna Sumaoang. Sales enablement is a constantly evolving space, and we’re here to help professionals stay up to date on the latest trends and best practices so they can be more effective in their jobs.
Today, I’m excited to have Rebecca Bell from IQVIA join us. Rebecca, I would love for you to introduce yourself, your role, and your organization to our audience.
Rebecca Bell: Well, thanks for having me. It’s great to be here. I’m Rebecca Bell, and I’m...2020-04-0400 minSales Enablement PRO PodcastEpisode 70: Rebecca Bell on 4 Actionable Tips for Virtual EnablementShawnna Sumaoang: Hi, and welcome to the Sales Enablement PRO podcast. I am Shawnna Sumaoang. Sales enablement is a constantly evolving space, and we’re here to help professionals stay up to date on the latest trends and best practices so they can be more effective in their jobs.
Today, I’m excited to have Rebecca Bell from IQVIA join us. Rebecca, I would love for you to introduce yourself, your role, and your organization to our audience.
Rebecca Bell: Well, thanks for having me. It’s great to be here. I’m Rebecca Bell, and I’m...2020-03-3000 min
The MM+M PodcastEpisode 48: IQVIA Institute's Murray AitkenCovid-19 will mark a turning point in AI’s utility to combat an outbreak, said this week's podcast guest, Murray Aitken. As executive director of the IQVIA Institute for Human Data Science, Aitken spoke with MM&M’s executive editor, Marc Iskowitz, about the potential of big data to help track and predict the outbreak’s spread, as well as other areas where healthcare is combining science with analytics to improve understanding, from Alzheimer’s research to healthcare marketing.
Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC...2020-02-2640 min
The MM+M PodcastEpisode 48: IQVIA Institute's Murray AitkenCovid-19 will mark a turning point in AI’s utility to combat an outbreak, said this week's podcast guest, Murray Aitken. As executive director of the IQVIA Institute for Human Data Science, Aitken spoke with MM&M’s executive editor, Marc Iskowitz, about the potential of big data to help track and predict the outbreak’s spread, as well as other areas where healthcare is combining science with analytics to improve understanding, from Alzheimer’s research to healthcare marketing.2020-02-2640 min
The MM+M PodcastEpisode 16: IQVIA's Michael KleinrockWhat can data tell us about the opioid crisis? IQVIA’s Michael Kleinrock, who trained as a journalist and is now a research director at the firm’s Institute for Human Data Science, joins us from the floor of the BIO convention, taking place in Philadelphia this week, to discuss a panel he moderated on solutions to curbing the epidemic. Kleinrock theorizes as to why neither prescribing patterns (which are at an eight-year low) nor logistics nor current policies have made a dent, as well as the human intersection and need to preserve access amidst the crisis.2019-06-0531 min
Nephron Research LLCSetting the Stage: Demystifying Gross-to-Net with IQVIAMichael Kleinrock, Director Research Development, IQVIA Institute 2019-04-1543 min
Modernizing Clinical Trials with IQVIA's Dr Cynthia VerstModernizing Clinical Trials with IQVIA's Dr Cynthia Verst
Host: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm:Disrupting Clinical Trials
Guest: Dr Cynthia Verst, President, Design and Delivery Innovation for the Research & Development Solutions organization at IQVIA2019-04-0125 min
PharmaTalkRadioModernizing Clinical Trials with IQVIA's Dr Cynthia VerstModernizing Clinical Trials with IQVIA's Dr Cynthia Verst Host: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm:Disrupting Clinical Trials Guest: Dr Cynthia Verst, President, Design and Delivery Innovation for the Research & Development Solutions organization at IQVIA2019-04-0124 min
Clinical Trial Podcast | Conversations with Clinical Research ExpertsCTP 015: Real-World Insights and Epidemiology with Dr. Christina MackChristina Mack, Ph.D., MSPH is Sr. Director of Epidemiology and Clinical Evidence in the IQVIA Real-World Insights division. She is a recognized expert in effectiveness studies for medical devices and pharmaceutical products, sports injury research, and pharmacoepidemiology methods including the use of external comparators, propensity scores, instrumental variables, and missing data. Her work focuses on the use of electronic health record systems and claims data for research, with a focus in study design methodology, maternal health, orthopedics, oncology, and infectious disease. Dr. Mack oversees development of large evidence hubs and novel studies th...2018-09-241h 24PharmaPills - Pillole dal farmaceuticoPharmapills puntata n.71. Studi clinici: Iqvia acquisisce il 100% della modenese Medineos.PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Menarini, Medineos, Iqvia, Novartis.Persone: Luca Li BassiNuove terapie: Kymriah, riluzolo.Patologie: Alzheimer, leucemia linfoblastica acuta, SLA.Lavoro: Clinical Research Associate, Clinical Reserach Associate - Site and Patient Access, Senior MSL - Internal Medicine.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/2018-09-1212 minPharmaPills - Pillole dal farmaceuticoPharmapills puntata n.70. Pubblicato il report Global Oncology Trends 2018 di IqviaPharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Gilead Sciences, Sierra Oncology, Novo Nordisk, Ziylo, FDA, MSD, GSK, IQVIA.Persone: Nick Glover (Sierra Oncology), Vincenzo Palermo (Gilead).Nuove terapie: momelotinib, nivolumab, rilpivirine, cabotegravir.Patologie: cancro, tumore al polmone, AIDS.Lavoro: CRA II, Senior CRA, CRA.Il mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/2018-08-2908 min